Although the critical role of FGFR4 in metastasis has been demonstrated in animal models of several cancers, prospective studies are warranted to provide evidence regarding the therapeutic efficacy of FGFR4 inhibitors in clinical metastatic cancers. The gene discussed is FGFR4; the disease is cancer.